Conflicts of interest: Nothing to report.
Coronary Artery Disease
Innovative use of self-expanded polytetrafluoroethylene endoprosthesis for percutaneous endovascular interventions
Article first published online: 8 OCT 2012
Copyright © 2011 Wiley Periodicals, Inc.
Catheterization and Cardiovascular Interventions
Volume 81, Issue 4, pages 719–726, March 2013
How to Cite
Maluenda, G., Waksman, R. and Bernardo, N. L. (2013), Innovative use of self-expanded polytetrafluoroethylene endoprosthesis for percutaneous endovascular interventions. Cathet. Cardiovasc. Intervent., 81: 719–726. doi: 10.1002/ccd.23498
- Issue published online: 22 FEB 2013
- Article first published online: 8 OCT 2012
- Manuscript Accepted: 21 NOV 2011
- Manuscript Received: 9 JUN 2011
- endovascular intervention;
VIABAHN® endoprosthesis (Gore & Associates, Flagstaff, AZ), a nitinol self-expanding polytetrafluoroethylene (PTFE) lined stent, has demonstrated utility for percutaneous treatment of chronic occlusive disease involving the superficial femoral artery. In a case series communication we aimed to describe the feasibility of a PTFE-lined stent for percutaneous treatment of conditions other than chronic occlusive disease. We report the successful use of PTFE-endoprosthesis to percutaneously treat several vascular conditions, including arterio–venous fistula closure, reconstruction of a distal limb of an aorto–femoral endoprosthesis aneurysm, femoral artery perforation repair, and an exclusion of large saphenous vein graft aorto–coronary bypass aneurysm. This case series illustrates the feasibility of the “off-label” use of self-expanded PTFE endoprosthesis to percutaneously treat several conditions, which would otherwise require “open” surgical reconstructions. © 2011 Wiley Periodicals, Inc.